Identity
HGNC
LOCATION
10q23.33
LOCUSID
ALIAS
CPC9,CYP2C,CYP2C10,CYPIIC9,P450IIC9
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 1559
MIM: 601130
HGNC: 2623
Ensembl: ENSG00000138109
Variants:
dbSNP: 1559
ClinVar: 1559
TCGA: ENSG00000138109
COSMIC: CYP2C9
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000138109 | ENST00000260682 | P11712 |
| ENSG00000138109 | ENST00000260682 | S5RV20 |
| ENSG00000138109 | ENST00000461906 | P11712 |
| ENSG00000138109 | ENST00000643112 | A0A2R8YF67 |
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
PharmGKB
| Entity ID | Name | Type | Evidence | Association | PK | PD | PMIDs |
|---|---|---|---|---|---|---|---|
| PA10034 | bosentan | Chemical | VariantAnnotation | ambiguous | PK | PD | 24048276, 24842639 |
| PA10075 | esomeprazole | Chemical | LabelAnnotation | associated | |||
| PA10233 | voriconazole | Chemical | LabelAnnotation, VariantAnnotation | ambiguous | PK | 26886310 | |
| PA10390 | sulfonamides, urea derivatives | Chemical | ClinicalAnnotation | associated | PD | 19794412, 24442125, 29681852 | |
| PA10892 | gliclazide | Chemical | GuidelineAnnotation, VariantAnnotation | associated | 24442125 | ||
| PA124 | CYP2C19 | Gene | DataAnnotation | associated | |||
| PA131301952 | gefitinib | Chemical | Literature, MultilinkAnnotation | associated | 24433361 | ||
| PA131890625 | tenoxicam | Chemical | ClinicalAnnotation, GuidelineAnnotation, VariantAnnotation | associated | PK | 15229460, 18992346 | |
| PA133787052 | VKORC1 | Gene | DataAnnotation, VipGene | associated | 12931134, 14765194, 14765195, 15358623, 15597574, 15865594, 15930419, 15938684, 16888441, 16960144, 16983400, 17124101, 9684798, 11926893 | ||
| PA133950441 | hmg coa reductase inhibitors | Chemical | Pathway | associated | |||
| PA134308647 | rosuvastatin | Chemical | VariantAnnotation | not associated | PK | 23930675 | |
| PA134852920 | benzbromarone | Chemical | MultilinkAnnotation, VariantAnnotation | associated | PK | 20962433, 25876828 | |
| PA143485705 | antiepileptics | Chemical | VariantAnnotation | associated | PD | ||
| PA154410481 | prasugrel | Chemical | LabelAnnotation | associated | |||
| PA162316739 | Maculopapular Exanthema | Disease | ClinicalAnnotation, VariantAnnotation | ambiguous | PD | 20941486, 25096692 | |
| PA164712462 | Antiinflammatory agents, non-steroids | Chemical | ClinicalAnnotation | associated | PD | 17681167 | |
| PA164744895 | gliquidone | Chemical | VariantAnnotation | associated | 24442125 | ||
| PA164746757 | tolterodine | Chemical | LabelAnnotation | associated | |||
| PA164784021 | ethambutol | Chemical | ClinicalAnnotation | associated | PD | 20941486 | |
| PA165108401 | Acute coronary syndrome | Disease | ClinicalAnnotation | associated | PK | PD | 17900275, 19463375, 19934793, 20833683, 21831410, 22990067, 27756942 |
| PA165111675 | Drug Resistance | Disease | VariantAnnotation | associated | PD | ||
| PA165816542 | CYP2C9*1 | Haplotype | LabelAnnotation | associated | |||
| PA165816543 | CYP2C9*2 | Haplotype | GuidelineAnnotation, LabelAnnotation, VipGene | associated | 11927841, 14597963, 15469410, 15637526, 16863464, 19151603, 8004131, 9241660, 11337938 | ||
| PA165816544 | CYP2C9*3 | Haplotype | GuidelineAnnotation, LabelAnnotation, VipGene | associated | 11927841, 12698304, 14597963, 15289789, 15637526, 19082874, 10761997 | ||
| PA165816546 | CYP2C9*5 | Haplotype | GuidelineAnnotation | associated | |||
| PA165816547 | CYP2C9*6 | Haplotype | GuidelineAnnotation | associated | |||
| PA165816549 | CYP2C9*8 | Haplotype | GuidelineAnnotation | associated | |||
| PA165816552 | CYP2C9*11 | Haplotype | GuidelineAnnotation | associated | |||
| PA165954769 | HLA-B*15:02:01 | Haplotype | LabelAnnotation | associated | |||
| PA165958395 | lornoxicam | Chemical | ClinicalAnnotation, GuidelineAnnotation, VariantAnnotation, VipGene | associated | PK | 15764711, 16182270, 16342679 | |
| PA165980614 | fluindione | Chemical | GuidelineAnnotation, VariantAnnotation | ambiguous | PK | ||
| PA166119041 | drug-induced liver injury | Disease | VariantAnnotation | ambiguous | PD | 24842639 | |
| PA166120927 | drug reaction with eosinophilia and systemic symptoms | Disease | VariantAnnotation | ambiguous | PD | 25096692, 29458119 | |
| PA166120929 | severe cutaneous adverse reactions | Disease | VariantAnnotation | associated | PD | 25994870 | |
| PA166122646 | hemopoietic stem cell transplant | Disease | ClinicalAnnotation | associated | PK | 24165757 | |
| PA166123298 | over-anticoagulation | Disease | VariantAnnotation | ambiguous | PD | 11692083, 11926893, 12414349, 12634980, 14614357, 15001971, 15116052, 15128048, 15536456, 16815313, 17226852, 17324110, 17989110, 18690342, 18781852, 19225451, 19794411, 20354686, 21318593, 22252093, 22571356, 22990331, 23016521, 23104259, 23279643, 23602689, 24911077, 24919870, 24956252, 25769357 | |
| PA166123431 | heart valve replacement | Disease | ClinicalAnnotation, VariantAnnotation | associated | PD | 11926893, 17324110, 17955230, 18322281, 18690342, 19077919, 23279643, 24474498, 25504915, 29396738 | |
| PA166123766 | platelet aggregation | Disease | VariantAnnotation | ambiguous | PD | 28745576 | |
| PA166124478 | endoxifen | Chemical | VariantAnnotation | not associated | PK | 15632378, 29436156 | |
| PA166127651 | n-desmethyltamoxifen | Chemical | VariantAnnotation | not associated | PK | 29436156 | |
| PA166127652 | 4-hydroxytamoxifen | Chemical | VariantAnnotation | ambiguous | PK | 29436156 | |
| PA166129530 | time to achieve stable dose | Disease | VariantAnnotation | ambiguous | PD | 11926893, 15116052, 16815313, 17324110, 17955230, 18690342, 21057703, 23279643, 24956252 | |
| PA166129531 | time in therapeutic range | Disease | VariantAnnotation | ambiguous | PD | 10961881, 12414349, 17226852, 17955230, 18690342, 26469104, 27511999 | |
| PA166129532 | time to therapeutic inr | Disease | VariantAnnotation | ambiguous | PD | 11926893, 17226852, 19794411, 20339978, 20386359, 20833980, 21148049, 21318593, 22571356, 23279643, 29396738 | |
| PA166129534 | time above therapeutic range | Disease | VariantAnnotation | associated | PD | 26469104 | |
| PA166129560 | major adverse cardiac events (mace) | Disease | VariantAnnotation | not associated | PD | 28745576 | |
| PA166129562 | time below therapeutic range | Disease | VariantAnnotation | associated | PD | 23016521 | |
| PA166131388 | 4-hydroxycyclophosphamide | Chemical | VipGene | associated | 18496131, 12684728 | ||
| PA166151827 | adverse events | Disease | VariantAnnotation | not associated | PD | ||
| PA166153431 | flibanserin | Chemical | LabelAnnotation | associated | |||
| PA166153491 | brivaracetam | Chemical | LabelAnnotation | associated | |||
| PA166153959 | rs1057910 | Variant | VipGene | associated | 11927841, 12698304, 14597963, 15289789, 15637526, 19082874, 10761997 | ||
| PA166153972 | rs1799853 | Variant | VipGene | associated | 11927841, 14597963, 15469410, 15637526, 16863464, 19151603, 8004131, 9241660, 11337938 | ||
| PA166154157 | rs12777823 | Variant | GuidelineAnnotation | associated | |||
| PA166155091 | rs9923231 | Variant | GuidelineAnnotation, LabelAnnotation | associated | |||
| PA166155096 | rs9934438 | Variant | GuidelineAnnotation | associated | |||
| PA166155381 | rs2108622 | Variant | GuidelineAnnotation | associated | |||
| PA166160006 | lesinurad | Chemical | LabelAnnotation | associated | |||
| PA166163418 | rucaparib | Chemical | LabelAnnotation | associated | |||
| PA166179849 | avatrombopag | Chemical | LabelAnnotation | associated | |||
| PA166182720 | erdafitinib | Chemical | LabelAnnotation | associated | |||
| PA166182736 | siponimod | Chemical | GuidelineAnnotation, LabelAnnotation | associated | |||
| PA166182883 | ospemifene | Chemical | LabelAnnotation | associated | |||
| PA27121 | CYP4F2 | Gene | DataAnnotation | associated | |||
| PA28660 | GGCX | Gene | DataAnnotation | associated | |||
| PA443309 | Alcoholism | Disease | VariantAnnotation | associated | |||
| PA443459 | Atrial Fibrillation | Disease | ClinicalAnnotation, VariantAnnotation | ambiguous | PK | PD | 11926893, 15094935, 15970795, 17324110, 17955230, 18322281, 18690342, 19077919, 19387626, 20072124, 21590310, 21635147, 21981797, 22040439, 22534826, 22676192, 23113310, 23279643, 24108193, 24251363, 24474498, 25089947, 25504915, 25769357, 27121899, 29396738, 29479633, 29986700 |
| PA443460 | Atrial Flutter | Disease | VariantAnnotation | associated | PD | 29479633 | |
| PA443523 | Blood Coagulation Disorders | Disease | ClinicalAnnotation, VariantAnnotation | associated | PK | PD | 11692083, 12414349, 12634980, 14614357, 15116052, 15128048, 16815313, 18781852, 19225451, 22252093, 23651023, 24911077, 24919870, 24956252, 29479633 |
| PA443560 | Breast Neoplasms | Disease | VariantAnnotation | ambiguous | PK | PD | 15632378, 18024866, 29436156 |
| PA443635 | Cardiovascular Diseases | Disease | ClinicalAnnotation, VariantAnnotation | associated | PK | PD | 10509530, 11926893, 12496751, 12621390, 14656880, 15001971, 15094935, 15590403, 15841315, 15883587, 15947090, 16493479, 16890578, 17049586, 17391071, 17510308, 17851566, 17989110, 18756910, 18836275, 19031075, 19077919, 19135231, 19177029, 19582440, 19745563, 20421126, 21174619, 21185752, 21326313, 21590310, 21782804, 21981797, 22010099, 22040439, 22075505, 22349464, 22528326, 22534826, 22549502, 22594507, 22676192, 22854539, 22855348, 22892446, 22990331, 23061746, 23104259, 23183958, 23208322, 23279643, 23949431, 24029542, 24474498, 25042728, 25084205, 26517138, 29298995, 31395958, 31653973 |
| PA443636 | Carotid Artery Diseases | Disease | VariantAnnotation | not associated | PD | 26526111 | |
| PA443796 | Coronary Artery Disease | Disease | ClinicalAnnotation | associated | PK | PD | 17900275, 19463375, 19934793, 20833683, 21831410, 22990067, 27756942 |
| PA443886 | Diabetes Mellitus | Disease | VariantAnnotation | associated | 24442125 | ||
| PA443890 | Diabetes Mellitus, Type 2 | Disease | ClinicalAnnotation | associated | PD | 19794412, 24442125, 29681852 | |
| PA443937 | Drug Toxicity | Disease | ClinicalAnnotation, VariantAnnotation | associated | PK | PD | 22641027, 26658169 |
| PA444059 | Epidermal Necrolysis, Toxic | Disease | VariantAnnotation | associated | PD | 25096692, 26928377 | |
| PA444065 | Epilepsy | Disease | ClinicalAnnotation, VariantAnnotation | ambiguous | PK | PD | 10774639, 10901705, 11434505, 11668218, 11673755, 12707459, 14659971, 15024534, 15385837, 16815679, 19030785, 20390258, 21068649, 21338443, 21532277, 21537551, 22641027, 25096692, 25162219, 25597548, 25994870, 25998968, 26122019, 26928377, 27163851, 9333104, 9860067 |
| PA444250 | Gastritis | Disease | VariantAnnotation | associated | PD | 26517138 | |
| PA444368 | Heart Diseases | Disease | ClinicalAnnotation, VariantAnnotation | associated | PK | PD | 10509530, 11926893, 12496751, 12621390, 14656880, 15001971, 15094935, 15590403, 15841315, 15883587, 15947090, 16493479, 16890578, 17049586, 17391071, 17510308, 17851566, 17989110, 18756910, 18836275, 19031075, 19077919, 19135231, 19177029, 19582440, 19745563, 20421126, 21174619, 21185752, 21326313, 21590310, 21782804, 21981797, 22010099, 22040439, 22075505, 22349464, 22528326, 22534826, 22549502, 22594507, 22676192, 22854539, 22855348, 22892446, 22990331, 23061746, 23104259, 23183958, 23208322, 23279643, 23949431, 24029542, 24474498, 25042728, 25084205, 29298995, 31395958, 31653973 |
| PA444398 | Hematoma, Subdural | Disease | VariantAnnotation | associated | PD | ||
| PA444417 | Hemorrhage | Disease | ClinicalAnnotation, MultilinkAnnotation, VariantAnnotation | ambiguous | PD | 10509530, 11926893, 12414349, 12728288, 12876643, 14676821, 15213846, 15714076, 16699986, 17653141, 17955230, 18570163, 18574025, 18690342, 18752379, 18756910, 18950464, 19297219, 21148049, 22571356, 23104259, 23113310, 23348161, 23602689, 23774101, 23932037, 24474498, 24503627, 24602049, 25001883, 25244877, 25521356, 25585969, 25769357, 25858232, 26777610, 27488176, 27581200, 28033245, 28689179, 29432897, 29577257 | |
| PA444516 | Hypercholesterolemia | Disease | VariantAnnotation | not associated | PK | 23930675 | |
| PA444552 | Hypertension | Disease | VariantAnnotation | ambiguous | PD | 18971529 | |
| PA444555 | Hypertension, Pulmonary | Disease | VariantAnnotation | not associated | PD | 24842639 | |
| PA444570 | Hypoglycemia | Disease | VariantAnnotation | associated | 24442125 | ||
| PA444584 | Hypotension | Disease | ClinicalAnnotation, VariantAnnotation | associated | PD | 23559402 | |
| PA444682 | Kidney Diseases | Disease | VariantAnnotation | associated | PD | ||
| PA444773 | Leukopenia | Disease | VariantAnnotation | associated | PD | 26894931 | |
| PA445019 | Myocardial Infarction | Disease | VariantAnnotation | not associated | PD | ||
| PA445043 | Opioid-Related Disorders | Disease | VariantAnnotation | not associated | PK | 17178267 | |
| PA445062 | Neoplasms | Disease | VariantAnnotation | ambiguous | PD | 17226852 | |
| PA445208 | Pain | Disease | VariantAnnotation | associated | PD | ||
| PA445465 | Pulmonary Embolism | Disease | ClinicalAnnotation, VariantAnnotation | associated | PK | PD | 15094935, 15970795, 19387626, 20072124, 21590310, 21635147, 22676192, 27121899, 29986700 |
| PA445506 | Recurrence | Disease | VariantAnnotation | not associated | PD | 18024866 | |
| PA445553 | Rheumatic Heart Disease | Disease | VariantAnnotation | associated | PD | 27335128 | |
| PA445676 | Skin Diseases | Disease | VariantAnnotation | not associated | PD | 29458119 | |
| PA445738 | Stevens-Johnson Syndrome | Disease | VariantAnnotation | associated | PD | 25096692, 26928377 | |
| PA445848 | Thromboembolism | Disease | VariantAnnotation | associated | PK | PD | 22528326 |
| PA445862 | Thyrotoxicosis | Disease | VariantAnnotation | associated | PD | ||
| PA445941 | Tuberculosis | Disease | ClinicalAnnotation | associated | PD | 20941486 | |
| PA446023 | Vasculitis | Disease | VariantAnnotation | associated | PD | 26894931 | |
| PA446065 | Wegener Granulomatosis | Disease | VariantAnnotation | associated | PD | 26894931 | |
| PA446813 | Gingival Overgrowth | Disease | VariantAnnotation | not associated | PD | 14659971 | |
| PA446969 | Venous Thrombosis | Disease | ClinicalAnnotation, VariantAnnotation | associated | PK | PD | 15094935, 15970795, 19387626, 20072124, 21590310, 21635147, 22676192, 27121899, 29479633, 29986700 |
| PA447054 | Stroke | Disease | ClinicalAnnotation, VariantAnnotation | ambiguous | PK | PD | 15094935, 15970795, 19387626, 20072124, 21590310, 21635147, 22676192, 25989350, 27121899, 29986700 |
| PA447199 | Bipolar Disorder | Disease | ClinicalAnnotation, VariantAnnotation | ambiguous | PK | PD | 27353638 |
| PA447207 | Depressive Disorder | Disease | VariantAnnotation | not associated | PD | 24663076 | |
| PA447208 | Mental Disorders | Disease | VariantAnnotation | ambiguous | PK | 14726986, 18677622 | |
| PA447215 | Psychotic Disorders | Disease | ClinicalAnnotation, VariantAnnotation | ambiguous | PK | PD | 27353638 |
| PA447216 | Schizophrenia | Disease | VariantAnnotation | not associated | PK | 15260906 | |
| PA447230 | HIV | Disease | VariantAnnotation | associated | PD | 11186133 | |
| PA447276 | Thrombosis of cerebral veins | Disease | VariantAnnotation | associated | PD | 24530212 | |
| PA447288 | Essential hypertension | Disease | ClinicalAnnotation | associated | PK | PD | 16094537, 21842338 |
| PA447298 | venous thromboembolism | Disease | VariantAnnotation | associated | PD | 20421126, 24251363, 25089947 | |
| PA447321 | Depressive Disorder, Major | Disease | VariantAnnotation | ambiguous | PK | 16236141 | |
| PA448497 | aspirin | Chemical | VariantAnnotation | associated | PD | 20833683, 26517138 | |
| PA448500 | atorvastatin | Chemical | Pathway | associated | |||
| PA448691 | busulfan | Chemical | ClinicalAnnotation, VariantAnnotation | associated | PK | 24165757 | |
| PA448817 | carvedilol | Chemical | LabelAnnotation, VariantAnnotation | ambiguous | PK | 21599570 | |
| PA448871 | celecoxib | Chemical | ClinicalAnnotation, GuidelineAnnotation, LabelAnnotation, Pathway, VariantAnnotation, VipGene | associated | PK | PD | 11337938, 12893985, 16153401, 16401468, 17681167, 22336956, 23996211, 25585969, 26360837, 27864660 |
| PA449053 | clopidogrel | Chemical | ClinicalAnnotation, Pathway, VariantAnnotation | ambiguous | PK | PD | 17900275, 19463375, 19934793, 20833683, 20938371, 21831410, 22929815, 22990067, 24262617, 26526111, 27756942, 28745576 |
| PA449165 | cyclophosphamide | Chemical | VariantAnnotation, VipGene | associated | PD | 18496131, 12684728, 26894931 | |
| PA449211 | dapsone | Chemical | VariantAnnotation | not associated | PD | 29458119 | |
| PA449283 | diazepam | Chemical | VariantAnnotation | associated | PK | PD | 22641027 |
| PA449293 | diclofenac | Chemical | ClinicalAnnotation, VariantAnnotation, VipGene | associated | PK | PD | 17681167, 20814155, 23400009, 23959274, 25994031, 8417277 |
| PA449409 | doxepin | Chemical | ClinicalAnnotation, Pathway, VariantAnnotation | associated | PK | PD | 12360109 |
| PA449421 | dronabinol | Chemical | LabelAnnotation | associated | |||
| PA449653 | fluconazole | Chemical | VariantAnnotation | associated | PK | 26886310 | |
| PA449673 | fluoxetine | Chemical | Pathway, VariantAnnotation | ambiguous | PK | PD | 14726986, 16236141, 24663076 |
| PA449683 | flurbiprofen | Chemical | ClinicalAnnotation, GuidelineAnnotation, LabelAnnotation, VariantAnnotation | associated | PK | 12698304, 25712887, 32423989 | |
| PA449688 | fluvastatin | Chemical | ClinicalAnnotation, Pathway, VariantAnnotation, VipGene | ambiguous | PK | PD | 12891229, 17289397, 30363031, 7586933 |
| PA449761 | glimepiride | Chemical | GuidelineAnnotation, VariantAnnotation, VipGene | associated | 16325295, 12235454, 24442125 | ||
| PA449762 | glipizide | Chemical | VariantAnnotation, VipGene | associated | 10208645, 24442125 | ||
| PA449782 | glibenclamide | Chemical | GuidelineAnnotation, VariantAnnotation, VipGene | associated | 16342679, 24442125 | ||
| PA449957 | ibuprofen | Chemical | ClinicalAnnotation, GuidelineAnnotation, Pathway, VariantAnnotation | ambiguous | PK | PD | 12152005, 15289789, 18694831, 19480553, 25502615, 26122864 |
| PA449982 | indomethacin | Chemical | ClinicalAnnotation, VariantAnnotation | associated | PD | 12876643 | |
| PA450084 | irbesartan | Chemical | ClinicalAnnotation, MultilinkAnnotation | associated | PK | PD | 12359989, 16094537, 21842338 |
| PA450112 | isoniazid | Chemical | ClinicalAnnotation | associated | PD | 20941486 | |
| PA450268 | losartan | Chemical | ClinicalAnnotation, LabelAnnotation, Literature, MultilinkAnnotation, Pathway, VariantAnnotation, VipGene | ambiguous | PK | PD | 10096267, 11408373, 11823761, 15197523, 15289788, 18971529, 22294058, 22735459, 25303293, 25994031 |
| PA450272 | lovastatin | Chemical | Pathway | associated | |||
| PA450353 | meloxicam | Chemical | ClinicalAnnotation, GuidelineAnnotation, LabelAnnotation, VariantAnnotation, VipGene | associated | PK | 24322170, 24615047, 9493314 | |
| PA450401 | methadone | Chemical | VariantAnnotation | not associated | PK | 17178267 | |
| PA450595 | naproxen | Chemical | ClinicalAnnotation, VariantAnnotation, VipGene | ambiguous | PK | 17686967, 19280158, 32423989, 8866821 | |
| PA450600 | nateglinide | Chemical | Pathway, VariantAnnotation | associated | PK | 22842957 | |
| PA450616 | nevirapine | Chemical | Pathway | associated | |||
| PA450688 | olanzapine | Chemical | ClinicalAnnotation, VariantAnnotation | associated | PD | 23559402 | |
| PA450921 | phenprocoumon | Chemical | ClinicalAnnotation, DataAnnotation, GuidelineAnnotation, VariantAnnotation | ambiguous | PK | PD | 12728288, 15128047, 15128048, 15213846, 15536456, 15742978, 16847664, 18629445, 19319511, 20020283, 20376629, 20833980, 21057703, 21063236, 23016521, 23423913, 24224579, 26984978, 30207196 |
| PA450947 | phenytoin | Chemical | ClinicalAnnotation, DataAnnotation, GuidelineAnnotation, LabelAnnotation, Literature, MultilinkAnnotation, Pathway, VariantAnnotation, VipGene | ambiguous | PK | PD | 10208645, 10774639, 10901705, 11434505, 11668218, 11673755, 12707459, 14659971, 15024534, 15385837, 16220110, 16815679, 19030785, 20390258, 21068649, 21338443, 21532277, 21537551, 22569204, 22641027, 25096692, 25099164, 25162219, 25597548, 25994870, 25998968, 26122019, 26658169, 26928377, 27163851, 32423989, 9333104, 9860067 |
| PA450970 | pioglitazone | Chemical | VariantAnnotation | associated | PK | 28099407 | |
| PA450985 | piroxicam | Chemical | ClinicalAnnotation, GuidelineAnnotation, LabelAnnotation, VariantAnnotation | associated | PK | PD | 16198655, 17112811 |
| PA451141 | propofol | Chemical | VariantAnnotation | associated | PK | 24891132 | |
| PA451182 | pyrazinamide | Chemical | ClinicalAnnotation | associated | PD | 20941486 | |
| PA451250 | rifampin | Chemical | ClinicalAnnotation | associated | PD | 20941486 | |
| PA451257 | risperidone | Chemical | VariantAnnotation | not associated | PK | 15260906 | |
| PA451283 | rosiglitazone | Chemical | Pathway | associated | |||
| PA451333 | sertraline | Chemical | VariantAnnotation | not associated | PK | 18677622 | |
| PA451363 | simvastatin | Chemical | ClinicalAnnotation, Pathway, VariantAnnotation | ambiguous | PK | PD | 17289397, 22594507 |
| PA451544 | sulfamethoxazole | Chemical | VariantAnnotation | associated | PD | 11186133 | |
| PA451581 | tamoxifen | Chemical | Pathway, VariantAnnotation, VipGene | ambiguous | PK | PD | 15632378, 18024866, 23962908, 29436156 |
| PA451718 | tolbutamide | Chemical | ClinicalAnnotation, GuidelineAnnotation, VariantAnnotation, VipGene | associated | PK | 11875364, 15284535, 25994031, 27339126, 8742240 | |
| PA451791 | trimipramine | Chemical | ClinicalAnnotation, VariantAnnotation | associated | PK | 14520122 | |
| PA451846 | valproic acid | Chemical | ClinicalAnnotation, VariantAnnotation | ambiguous | PK | PD | 14597963, 27353638 |
| PA451906 | warfarin | Chemical | ClinicalAnnotation, DataAnnotation, GuidelineAnnotation, LabelAnnotation, Literature, MultilinkAnnotation, VariantAnnotation, VipGene | ambiguous | PK | PD | 8004131, 8747411, 8801057, 10073515, 10509530, 10961881, 11127854, 11926893, 12414349, 12496751, 12621390, 12634980, 12876643, 14521618, 14656880, 14676821, 15001971, 15094935, 15213846, 15590403, 15714076, 1581537, 15841315, 15883587, 15947090, 15970795, 16432637, 16493479, 16699986, 16863464, 16890578, 16983400, 17015052, 17049586, 17111199, 17226852, 17289397, 17324110, 17387222, 17391071, 17510308, 17653141, 17851566, 17955230, 17989110, 18030307, 18183038, 18305455, 18322281, 18466099, 18535201, 18542936, 18570163, 18574025, 18690342, 18698879, 18752379, 18756910, 18836275, 18950464, 19031075, 19074728, 19077919, 19135231, 19177029, 19228618, 19297219, 19300499, 19387626, 19582440, 19745563, 19752777, 19794411, 20072124, 20339191, 20339978, 20354686, 20386359, 20410877, 20421126, 20585834, 20833655, 20833980, 21110192, 21148049, 21174619, 21185752, 21228733, 21318593, 21326313, 21383771, 21590310, 21635147, 21725053, 21782804, 21900891, 21981797, 22010099, 22040439, 22075505, 22130800, 22248286, 22349464, 22528326, 22534826, 22549502, 22571356, 22594507, 22676192, 22854539, 22855348, 22892446, 22990331, 23061746, 23104259, 23113310, 23159229, 23183958, 23208322, 23279643, 23348161, 23582453, 23602689, 23688605, 23774101, 23932037, 23941071, 23949431, 24019055, 24029542, 24088130, 24251363, 24330000, 24474498, 24503627, 24602049, 24728385, 24911077, 25001883, 25026456, 25042728, 25075423, 25084205, 25126975, 25244877, 25312789, 25504915, 25521356, 25594941, 25712185, 25769357, 25858232, 25989350, 25994031, 26010205, 26219158, 26223945, 26257249, 26469104, 26777610, 27121899, 27488176, 27488389, 27511999, 27581200, 27617219, 27661060, 27878474, 28033245, 28049362, 28262345, 28429387, 28550460, 28689179, 28973620, 29054760, 29298995, 29396738, 29432897, 29577257, 29986700, 30821933, 31395958, 31653973, 32423989, 8004131, 9630825 |
| PA451949 | zafirlukast | Chemical | ClinicalAnnotation, VariantAnnotation | associated | PK | 27377818 | |
| PA451954 | zidovudine | Chemical | Pathway | associated | 22960662 | ||
| PA452632 | acenocoumarol | Chemical | ClinicalAnnotation, DataAnnotation, GuidelineAnnotation, LabelAnnotation, Literature, MultilinkAnnotation, VariantAnnotation | ambiguous | PK | PD | 10509530, 11186138, 11557918, 11692083, 11926893, 12010835, 12123234, 12414349, 12634980, 12844136, 12876643, 14521618, 14614357, 14676821, 15116052, 15116053, 15128048, 15213846, 15714076, 15790782, 16699986, 16815313, 16863464, 17653141, 17955230, 18021343, 18570163, 18574025, 18690342, 18756910, 18781852, 18950464, 19018719, 19225451, 19277427, 19297219, 19578179, 20020283, 21148049, 21811894, 22252093, 22486182, 22571356, 22629463, 22911785, 22920394, 23104259, 23113310, 23159639, 23348161, 23473641, 23481074, 23582453, 23602689, 23651023, 23774101, 23774941, 23932037, 24108193, 24474498, 24503627, 24530212, 24602049, 24911077, 24919870, 24956252, 25001883, 25042728, 25089947, 25244877, 25519826, 25521356, 25769357, 25858232, 26777610, 26781925, 27335128, 27488176, 27581200, 28033245, 28689179, 29432897, 29479633, 29577257, 30983536 |
| PA452637 | hormonal contraceptives for systemic use | Chemical | ClinicalAnnotation | associated | PD | 28750087 | |
| PA55 | APOE | Gene | DataAnnotation | associated | |||
| PA7000 | sorafenib | Chemical | Pathway | associated | 28362716 |
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37747773 | 2024 | Identification of the effects of pathogenic genetic variations of human CYP2C9 and CYP2D6: an in silico approach. | 0 |
| 37875597 | 2024 | Association of variants in the ABCB1, CYP2C19 and CYP2C9 genes for Juvenile Myoclonic Epilepsy. | 0 |
| 38227154 | 2024 | Genetic variation of CYP2C9 gene and its correlation with cardiovascular disease risk factors. | 0 |
| 37747773 | 2024 | Identification of the effects of pathogenic genetic variations of human CYP2C9 and CYP2D6: an in silico approach. | 0 |
| 37875597 | 2024 | Association of variants in the ABCB1, CYP2C19 and CYP2C9 genes for Juvenile Myoclonic Epilepsy. | 0 |
| 38227154 | 2024 | Genetic variation of CYP2C9 gene and its correlation with cardiovascular disease risk factors. | 0 |
| 36601711 | 2023 | Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic-pharmacodynamic model. | 1 |
| 36651185 | 2023 | Biotransformation of Bisphenol by Human Cytochrome P450 2C9 Enzymes: A Density Functional Theory Study. | 4 |
| 36718958 | 2023 | Effects of UGT1A, CYP2C9/19 and ABAT polymorphisms on plasma concentration of valproic acid in Chinese epilepsy patients. | 0 |
| 36787094 | 2023 | CYP2C9 Polymorphisms and the Risk of Cardiovascular Events in Patients Treated with Clopidogrel: Combined Data from the POPular Genetics and POPular AGE Trials. | 2 |
| 36855170 | 2023 | Global distribution of functionally important CYP2C9 alleles and their inferred metabolic consequences. | 10 |
| 36942299 | 2023 | The role of CYP2C9*2, CYP2C9*3 and VKORC1-1639 variants on the susceptibility of upper gastrointestinal bleeding: A full case-control study. | 3 |
| 36960518 | 2023 | Prevalence of CYP2C9 and CYP2C19 variants and the impact on clopidogrel efficacy in patients having CYPC19*2 variant. | 0 |
| 37008923 | 2023 | Identification and in vitro functional assessment of 10 CYP2C9 variants found in Chinese Han subjects. | 1 |
| 37222158 | 2023 | The frequency of major ABCG2, SLCO1B1 and CYP2C9 variants in Asian, Native Hawaiian and Pacific Islander women subgroups: implications for personalized statins dosing. | 0 |
Citation
Dessen P
CYP2C9 (cytochrome P450 family 2 subfamily C member 9)
Atlas Genet Cytogenet Oncol Haematol. 2003-08-01
Online version: http://atlasgeneticsoncology.org/gene/40245/cyp2c9
